According to a Future Market Insights (FMI) study, the global Biologic Excipients Market was valued at US$ 1.3 billion in 2021 and is expected to reach US$ 1.7 billion by 2028, representing a cumulative CAGR of 3.4% over the forecast period (2022-2028).
Request for Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6982
| Data Points | Market Insights | |
| Market Value 2022 | USD 1.4 Bn | |
| Market Value 2028 | USD 1.7 Bn | |
| CAGR 2022 – 2028 | 3.4% | |
| Top 5 Countries % Share | 61.1% | |
Global Biologic Excipients Market: Segmental Analysis & Forecast
Excipient type, end user, and region are the three segments of the global market. Based on excipient type, the market is divided into polymers, sugar alcohols, polysorbates, inorganic salts, amino acids, surfactants, and others. Polymers biologic excipients are expected to lead the biologic excipients market during the forecast period. The most revenue is generated by polymer biologic excipients, which are expected to grow at a 3.7% annual rate during the forecast period.
End users in the market are classified as biopharmaceutical manufacturers, contract research organizations/contract manufacturing organisations, and research organisations. Biopharmaceutical manufacturers will be the leading segment in the global biologic excipients market over the forecast period. This segment has a larger revenue share and is expected to grow at a 6.0% CAGR during the forecast period.
Global Biologic Excipients Market: Dynamics
Rising global demand for medicines, increased biologics uptake driving demand for parenteral formulations, increasing acquisition of contract research organisations, patent expiration of major blockbuster drugs, growing adoption of advanced drug delivery technologies, increasing research in paediatric formulations, growing demand for extended-release or sustained release formulations, and increasing demand for parenteral formulations are driving growth in the global biologics market.
However, a lack of proper data documentation on the gras status of excipients, regulatory audits limiting supply capacity, regulatory barriers discouraging novel excipient development, and excipient stability testing imposing cost liabilities on drug manufacturers are some of the factors expected to impede the growth of the global biologic excipients market during the forecast period.
Get a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-6982
The increasing adoption of continuous processing of biologic excipients, large drug manufacturers’ reliance on in-house biologic excipients production, a large proportion of imported excipients causing production delays, and regulatory harmonisation with regard to excipient gradation are all key trends in the biologic excipients market.
Furthermore, the growing importance of developing biologic excipients by big players to enhance their product portfolio, the growing importance of manufacturing authorization, the growing market for topical and parenteral applications, and mandatory licencing promoting demand for biologic excipients are the key trends likely to be observed in the global biologic excipients market.
Scope Of The Report
| Attribute | Details |
| Forecast Period | 2022 – 2028 |
| Historical Data Available for | 2013-2021 |
| Market Analysis | USD Million for Value. |
| Key Countries Covered | US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
| Key Segments Covered | Excipients Type, End Users and Region |
| Key Companies Profiled | • FMC Corporation
• Wacker Chemie AG • Evonik Industries AG • Ashland Global Holdings Inc., • Archer-Daniels-Midland Co., • Roquette Freres S.A., • The Dow Chemical Company, • Colorcon Inc., • Signet Chemical Co. Pvt. Ltd. • Sun Pharmaceutical Industries Ltd, |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Global Biologic Excipients Market: Regional Analysis
The North America regional market is projected to dominate the global biologic excipients market, accounting for a maximum revenue share of the global market by 2021 end. The North America, Western Europe, and Asia Pacific markets accounted for 77.3% of the total biologic excipients market share in terms of value in 2021. Revenue from the market in APEJ is estimated to expand at a CAGR of 4.2% over the forecast period.
Visit for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-6982
Biologic Excipients Market by Category
Excipient Type:
- Polymers
- Sugar Alcohols
- Polysorbates
- Inorganic Salts
- Amino Acids
- Surfactants
- Others
By End User:
- Biopharmaceutical Manufacturers
- Contract Research Organizations/Contract Manufacturing Organizations
- Research Organizations
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
